South Korea Women's Healthcare Market Research Report By Indication (Postmenopausal Osteoporosis, Infertility, Reproductive Health Management, Polycystic Ovary Syndrome, Gynecologic Cancer, Others), By Diagnosis (Bone Densitometry, Diagnostic Imaging Tests, Biopsies, Ovulation Testing, Others), By Treatment (Therapeutics, Surgeries, Others) and By End User (Hospitals Clinics, Gynecology Centers, Research Institutes, Others) - Growth & Industry Forecast 2025 To 2035
Forecast Period
2025 - 2035
CAGR
4.51%
2023 Market Size
$ 342 Million
2035 Market Size
$ 20.3 Billion
Healthcare● Updated July 2, 2026Report ID: MRFR/HC/43459-HCR|Pages: 200|Author: Rahul Gotadki
South Korea Womens Healthcare Market Summary
The South Korea Women's Healthcare Market is projected to grow from 12.5 USD Billion in 2024 to 20.3 USD Billion by 2035, reflecting a robust CAGR of 4.51%.
Key Market Trends & Highlights
South Korea Women's Healthcare Key Trends and Highlights
The market valuation is expected to increase from 12.5 USD Billion in 2024 to 20.3 USD Billion by 2035.
The compound annual growth rate (CAGR) for the period from 2025 to 2035 is estimated at 4.51%.
This growth trajectory suggests a rising demand for women's healthcare services and products in South Korea.
Growing adoption of advanced healthcare technologies due to increasing awareness of women's health issues is a major market driver.
Market Size & Forecast
2024 Market Size
12.5 (USD Billion)
2035 Market Size
20.3 (USD Billion)
CAGR (2025 - 2035)
4.51%
Major Players
SK Biopharmaceuticals, Genexine, Chong Kun Dang, DongA ST, Korea United Pharm, LG Chem, Hugel, Boryung Pharmaceutical, Celltrion, Yungjin Pharmaceutical, Hanmi Pharmaceutical, AhnGook Pharmaceutical, Samsung Biologics, Daewoong Pharmaceutical, Medtronic
Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry
South Korea Womens Healthcare Market Trends
Chronic Disease Awareness Drives Women's Health
The South Korea Women's Healthcare Market is currently experiencing significant trends driven by a combination of social, economic, and technological factors. One of the key market drivers is the increased awareness and focus on women's health issues, especially considering the rising rates of chronic diseases and conditions specific to women, such as breast and cervical cancers. With a growing elderly population and a shift towards preventive care, healthcare providers and government initiatives are implementing programs to enhance women's health services.
Opportunities in the women's healthcare sector are expanding, particularly in areas like reproductive health, maternal care, and mental health services. The South Korean government is using telemedicine as a way of policy intervention to improve women's health. Innovative technologies such as mobile health apps and wearables are also changing the scope for women to seek and monitor their health timely. There has been increased activity recently on online portals for health consultation and education, which marks progress toward the digitalization of women's healthcare. This is most evident in cities where busy schedules limit access to conventional healthcare services.
Digital Health and Mental Wellness Expand
Such people stand to significantly benefit from these services. Additionally, the increasing prevalence of mental health awareness among women is driving demand for specialized mental health services, which are beginning to be recognized as a crucial aspect of overall women's healthcare. Consequently, as South Korea embraces a more comprehensive approach to women's health, it opens doors for innovative solutions and healthcare delivery methods adaptable to women's unique needs.
South Korea Womens Healthcare Market Drivers
Rising Awareness of Women's Health Issues
The Global South Korea Women's Healthcare Market Industry is experiencing a notable increase in awareness regarding women's health issues. This heightened awareness is driven by educational campaigns and advocacy groups that emphasize the importance of preventive care and regular health check-ups. As a result, women are increasingly seeking healthcare services tailored to their specific needs. This trend is reflected in the projected market value of 12.5 USD Billion in 2024, indicating a growing recognition of women's health as a critical area of focus within the healthcare sector.
Market Segment Insights
Women's Healthcare Market Indication Insights
The South Korea Women's Healthcare Market is witnessing significant attention, particularly within the Indication segment, which encompasses crucial areas such as postmenopausal osteoporosis, infertility, reproductive health management, polycystic ovary syndrome, gynecologic cancer, and others. As more women in South Korea reach postmenopausal ages, the demand for effective solutions to manage osteoporosis has surged, given the increasing awareness surrounding women's bone health. Meanwhile, infertility has become a pressing concern, with rising numbers of couples seeking medical assistance; this trend is bolstered by societal shifts and advancements in assisted reproductive technologies, which are reshaping how infertility is approached in the nation.
Reproductive health management plays a vital role in ensuring women's holistic health, encompassing everything from menstrual health to preventive care and educational resources tailored to women's needs. The prevalence of polycystic ovary syndrome (PCOS) has drawn attention from healthcare providers and researchers alike, as this condition affects a significant number of women and requires ongoing management strategies.
Furthermore, gynecologic cancers represent a critical focus area, prompting initiatives aimed at enhancing awareness and screening among women in South Korea, given that early detection significantly improves outcomes. Overall, the emphasis on these indications highlights a broader trend: women's healthcare in South Korea is evolving, driven by both the growing recognition of specific health issues faced by women and the continuous advancements in medical technologies and treatments.
Women's Healthcare Market Diagnosis Insights
The Diagnosis segment of the South Korea Women's Healthcare Market plays a crucial role in the early identification and management of health conditions affecting women. This segment encompasses various techniques, such as bone densitometry, which is vital for assessing bone health, particularly in postmenopausal women who are at higher risk for osteoporosis. Diagnostic imaging tests, including mammography and ultrasound, provide essential data in detecting abnormalities and facilitating timely interventions.
Biopsies are significant for diagnosing conditions such as breast cancer, ensuring a more targeted treatment approach.Ovulation testing serves as an important tool for women looking to monitor their reproductive health, especially in the context of family planning and fertility treatments.
Overall, these diagnostic methods contribute to the improved health outcomes of women in South Korea, aligning with the broader trends in women's healthcare focusing on prevention and early detection. The growing emphasis on women's health issues and advancing technologies is expected to drive significant growth in this segment, reflecting the ongoing commitment to improving healthcare services for women across the region.
Women's Healthcare Market Treatment Insights
The Treatment segment of the South Korea Women's Healthcare Market plays a pivotal role in enhancing women's health outcomes through various interventions. The segment encompasses a range of approaches, including therapeutics and surgeries, which are essential in addressing health concerns unique to women. In particular, therapeutics are crucial for managing conditions such as reproductive health issues, hormonal imbalances, and chronic diseases prevalent among the female population.
Surgeries are often a significant aspect, particularly for conditions requiring surgical intervention like fibroids or cancers, which have seen advancements in minimally invasive techniques.Additionally, the segment covers other treatment modalities that cater to diverse women's health needs, further accentuating its importance. The South Korea Women's Healthcare Market is witnessing a paradigm shift towards innovative treatment solutions driven by advancements in medical technology and increasing awareness of women's health issues.
With a growing focus on personalized medicine and holistic approaches, this segment is expected to contribute significantly to the overall market's progression while addressing the unique healthcare challenges faced by women in South Korea.Rising investments in healthcare infrastructure and government initiatives to improve women's health signal promising opportunities for stakeholders in this segment to expand their offerings and enhance care delivery.
Women's Healthcare Market End User Insights
The South Korea Women's Healthcare Market has seen significant growth across various end user segments, with hospitals clinics being crucial in delivering comprehensive healthcare services tailored for women. This segment typically provides essential services ranging from maternity care to reproductive health, ensuring that women receive timely medical attention. Gynecology centers are also pivotal in this market, specializing in women's reproductive health needs and offering preventive care, diagnostics, and treatment options.
Research institutes contribute significantly to the advancement of women's health through innovative studies and clinical trials aimed at discovering new treatments and therapies.Additionally, other healthcare providers and community health organizations play an important role in outreach and education, enhancing awareness around women's health issues.
As South Korea's awareness of women's health issues grows, these end user segments are positioned to adapt and evolve, catering to the diverse needs of women in the region, thus driving market growth and improving health outcomes. The South Korea Women's Healthcare Market revenue reflects a comprehensive network that underscores the importance of specialized healthcare for women, necessitating continuous investment and attention.
Get more detailed insights about South Korea Womens Healthcare MarketRequest Free Sample
Key Players and Competitive Insights
The South Korea Women's Healthcare Market is a rapidly evolving landscape characterized by a growing emphasis on women's health issues, increased healthcare awareness, and advancements in medical technology. The sector is marked by a variety of specialized services and products designed to address the unique health needs of women, encompassing reproductive health, maternity services, hormonal therapies, and preventive care. Companies operating in this market face competition not only from domestic players but also from international firms who are keen on entering or expanding their presence in this region. The rise in healthcare expenditure, combined with a more health-conscious population and government support for healthcare advancements, creates a fertile environment for growth and innovation within the women's healthcare segment. This competitive landscape is further influenced by ongoing research and development efforts aimed at tackling various health issues, ensuring that stakeholders continuously adapt to meet evolving consumer needs.SK Biopharmaceuticals stands out in the South Korea Women's Healthcare Market due to its commitment to developing innovative solutions tailored to women's health concerns. The company has established a solid market presence driven by a strong portfolio of products that address conditions affecting women, such as hormonal imbalances and related disorders. SK Biopharmaceuticals leverages its extensive research capabilities to foster the development of new drugs, thereby maintaining a competitive edge in the market. Their strategic collaborations and partnerships with healthcare professionals ensure that they stay attuned to the specific needs of their female clientele, reinforcing their role as a key player in women's health. Additionally, their strong reputation for quality, safe, and effective medical products fosters trust among consumers and healthcare providers alike, positioning SK Biopharmaceuticals favorably in the eyes of target demographics.Genexine plays a crucial role in the South Korea Women's Healthcare Market through its emphasis on biopharmaceutical solutions designed for women’s health issues. The company is recognized for its innovative therapies and biologics aimed at treating conditions such as ovarian cancer and hormonal disorders. Genexine's robust pipeline of products, including key medical therapies tailored for women, underscores its strength in the market. Their commitment to research and development, accentuated by successful mergers and collaborations with international firms, enhances their growth prospects within the region. With a dedicated focus on proprietary technologies and a strong operational framework, Genexine not only contributes to improving women’s health outcomes in South Korea but also positions itself as a significant force in the evolving landscape of women’s healthcare, driving both product innovation and market expansion.
Key Companies in the South Korea Womens Healthcare Market include
Industry Developments
The South Korea Women's Healthcare Market is witnessing significant developments, with an increasing focus on innovative solutions for women's health. Companies like SK Biopharmaceuticals and Genexine have been advancing their research initiatives, concentrating on women's specific healthcare needs.
In August 2023, Medtronic launched a new initiative aimed at enhancing treatment options for female patients, showcasing a commitment to addressing gender-specific health challenges. Chong Kun Dang and DongA ST have also made strides in developing pharmaceuticals targeting reproductive health, reflecting a growing demand for specialized therapeutics.
Notably, in September 2023, Hanmi Pharmaceutical announced a strategic partnership with a local biotech firm, aiming to enhance its product pipeline in women’s health. The market is also seeing growth in investment and funding opportunities, with LG Chem and Samsung Biologics inflating their focus on biologics that cater specifically to women’s health issues.
The ongoing demand for personalized healthcare solutions is reinforcing market valuations across these companies, indicating a robust growth trajectory. Additionally, current affairs highlight increased government support for women's healthcare initiatives, aligning with South Korea's broader health policy objectives.
Future Outlook
South Korea Womens Healthcare Market Future Outlook
The South Korea Women's Healthcare Market is projected to grow at a 4.51% CAGR from 2025 to 2035, driven by technological advancements, increasing awareness, and demographic shifts.
New opportunities lie in:
Develop telehealth platforms tailored for women's health services. Invest in personalized medicine solutions for reproductive health. Expand access to mental health resources specifically for women.
By 2035, the market is expected to be robust, reflecting significant advancements and increased accessibility.
Market Segmentation
South Korea Women's Healthcare Market End User Outlook
Hospitals Clinics
Gynecology Centers
Research Institutes
Others
South Korea Women's Healthcare Market Diagnosis Outlook
Bone Densitometry
Diagnostic Imaging Tests
Biopsies
Ovulation Testing
Others
South Korea Women's Healthcare Market Treatment Outlook
Therapeutics
Surgeries
Others
South Korea Women's Healthcare Market Indication Outlook
Postmenopausal Osteoporosis
Infertility
Reproductive Health Management
Polycystic Ovary Syndrome
Gynecologic Cancer
Others
Report Scope
Report Attribute/Metric Source:
Details
MARKET SIZE 2023
342.0(USD Million)
MARKET SIZE 2024
372.0(USD Million)
MARKET SIZE 2035
744.0(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)
6.504% (2025 - 2035)
REPORT COVERAGE
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR
2024
MARKET FORECAST PERIOD
2025 - 2035
HISTORICAL DATA
2019 - 2024
MARKET FORECAST UNITS
USD Million
KEY COMPANIES PROFILED
SK Biopharmaceuticals, Genexine, Chong Kun Dang, DongA ST, Korea United Pharm, LG Chem, Hugel, Boryung Pharmaceutical, Celltrion, Yungjin Pharmaceutical, Hanmi Pharmaceutical, AhnGook Pharmaceutical, Samsung Biologics, Daewoong Pharmaceutical, Medtronic
SEGMENTS COVERED
Indication, Diagnosis, Treatment, End User
KEY MARKET OPPORTUNITIES
Telehealth services expansion, Menopause management solutions, Preventive screenings enhancement, Fertility treatment advancements, Mental health support programs
KEY MARKET DYNAMICS
aging population, increasing chronic diseases, rising healthcare expenditure, growing awareness and education, technological advancements in treatments
COUNTRIES COVERED
South Korea
FAQs
What is the expected market size of the South Korea Women's Healthcare Market in 2024?
The South Korea Women's Healthcare Market is expected to be valued at 372.0 million USD in 2024.
What will the market value be for South Korea Women's Healthcare Market by the year 2035?
By 2035, the South Korea Women's Healthcare Market is projected to reach a value of 744.0 million USD.
What is the expected compound annual growth rate (CAGR) for the South Korea Women's Healthcare Market from 2025 to 2035?
The expected CAGR for the South Korea Women's Healthcare Market from 2025 to 2035 is 6.504%.
Which indication holds the highest market value in the South Korea Women's Healthcare Market for 2024?
For 2024, reproductive health management holds the highest market value at 90.0 million USD.
How is the market value of postmenopausal osteoporosis expected to change from 2024 to 2035?
The market value for postmenopausal osteoporosis is expected to grow from 74.0 million USD in 2024 to 148.0 million USD in 2035.
What is the projected market size for infertility in the South Korea Women's Healthcare Market by 2035?
The projected market size for infertility by 2035 is 130.0 million USD.
Who are the key players in the South Korea Women's Healthcare Market?
Major players include SK Biopharmaceuticals, Genexine, Chong Kun Dang, and LG Chem among others.
What is the expected value for gynecologic cancer treatment in the South Korea Women's Healthcare Market in 2024?
The expected market value for gynecologic cancer treatment in 2024 is 83.0 million USD.
What challenges might impact the growth of the South Korea Women's Healthcare Market?
Challenges may include regulatory hurdles and the need for advanced healthcare technology.
What are the key growth drivers for the South Korea Women's Healthcare Market?
Key growth drivers include increasing awareness of women's health issues and advancements in medical technology.
Author
Author
Rahul Gotadki
Research Manager
He holds an experience of about 9+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.
No country-specific reports available for this market.
Customer Stories
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
Noah MalgeriCo-Founder
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
Joseph AguayoSales Operations & Pricing Manager
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
Peter Groot koerkampAccount and Business Manager
“Thank you, this will be very helpful for OQS.”
La Terria DoddProgram Support Specialist
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
Younghwan ChoiSenior Retail Manager
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile").
In general the report is well structured. Thanks very much for your efforts.”
Mark IrwinManagement Consultant
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
Rob KooikerGroup Product Manager HVAC & Fire Protection GMA
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”
Akif MorogluStrategy & Business Development Director
“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”
Guilherme Gomes MartinsProduct Management Director